In Vivo Administration of Anti-CD3 Prevents Malignant Progressor Tumor Growth-Reference-Cited by-同舟云学术

In Vivo Administration of Anti-CD3 Prevents Malignant Progressor Tumor Growth

Published:1988-10-28 Issue:4878 Volume:242 Page:569-571
ISSN:0036-8075
Container-title:Science
language:en
Short-container-title:Science

Author:

Ellenhorn Joshua D. I.¹,Hirsch Raphael²,Schreiber Hans¹,Bluestone Jeffrey A.¹

Affiliation:

1. University of Chicago, IL 60637.

2. National Cancer Institute, Bethesda, MD 20892.

Publisher

American Association for the Advancement of Science (AAAS)

Subject

Multidisciplinary

Reference9 articles.

1. New England Journal of Medicine 313: 337 (1985).

2. BLUESTONE J.A. unpublished data.

3. CARSWELL, E.A., ENDOTOXIN-INDUCED SERUM FACTOR THAT CAUSES NECROSIS OF TUMORS, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 72: 3666 (1975).

4. ESPEVIK, T, A HIGHLY SENSITIVE CELL-LINE, WEHI-164 CLONE 13, FOR MEASURING CYTOTOXIC FACTOR TUMOR-NECROSIS-FACTOR FROM HUMAN-MONOCYTES, JOURNAL OF IMMUNOLOGICAL METHODS 95: 99 (1986).

5. HIRSCH, R, EFFECTS OF INVIVO ADMINISTRATION OF ANTI-T3 MONOCLONAL-ANTIBODY ON T-CELL FUNCTION IN MICE .1. IMMUNOSUPPRESSION OF TRANSPLANTATION RESPONSES, JOURNAL OF IMMUNOLOGY 140: 3766 (1988).

Cited by 91 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drug overdose deaths during prison riots and mental states of prisoners: a case study;Frontiers in Psychiatry;2024-09-13

2. A multi-functional drug delivery nanosystem release of TLR-7 immunostimulant and OKT3 induced efficient cancer immunotherapy;Photodiagnosis and Photodynamic Therapy;2023-12

3. Modulating T Cell Responses by Targeting CD3;Cancers;2023-02-13

4. Therapeutic antibodies for precise cancer immunotherapy: current and future perspectives;Medical Review;2022-12-01

5. Evaluation the potential of recombinant anti-CD3 nanobody on immunomodulatory function;Molecular Immunology;2020-02